Ardelyx (ARDX)
(Delayed Data from NSDQ)
$6.45 USD
-0.29 (-4.30%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $6.45 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Ardelyx, Inc. [ARDX]
Reports for Purchase
Showing records 101 - 120 ( 172 total )
Company: Ardelyx, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Ph 3 Success Sets up Potential Tenapanor Launch within Two Years
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ardelyx, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
HEALTHCARE - 2017 PacGrow Healthcare Conference: Day 2 Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Ardelyx, Inc.
Industry: Medical - Drugs
2Q - $50M EV Significantly Undervalues Potential of Ph 3 Pipeline
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ardelyx, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences: Upcoming Events for the Week of Aug 7
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ardelyx, Inc.
Industry: Medical - Drugs
T3MPO-1 Data Hits Primary, Supports Approvability but Appears not as Competitive as Hoped, Maintain OP, Cutting PT to $14
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ardelyx, Inc.
Industry: Medical - Drugs
T3MPO-1 Data Hits Primary, Supports Approvability but Appears not as Competitive as Hoped, Maintain OP, Cutting PT to $14
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Wedbush Best Ideas List Update.
Provider: WEDBUSH SECURITIES INC.
Company: Ardelyx, Inc.
Industry: Medical - Drugs
1Q, Recommending Shares Ahead of Pivotal 3 IBS-C Readout Anticipated Later this Q
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Best Ideas List: Update
Provider: WEDBUSH SECURITIES INC.
Company: Ardelyx, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences: Upcoming Events for the Week of April 24
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ardelyx, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences Upcoming Events for the Week of April 10.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Best Ideas List: Update
Provider: WEDBUSH SECURITIES INC.
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Best Ideas List: Update
Provider: WEDBUSH SECURITIES INC.